An international team of researchers have developed a pill, which can successfully fight common cold.

The recent study has shown that ‘BTA798’ can effectively fight the bugs that cause half of colds in adults and almost all colds in children.

This pill has given positive lab results. Human trails of this drug are still going on.

Researchers affirm that this drug can be used to prevent any kind of life-threatening infections in asthma and cystic fibrosis sufferers. It can also clear up sniffles in healthy people within a few hours.

This drug prevents cold-causing HRV from breaking into the body's cells and causing infection. It also stops any infection from spreading in a double-pronged attack.

Peter Cook of Victoria-based Biota Holdings, developer of the drug said, “It's a significant milestone in the development of what could be a world-first antiviral treatment for HRV (human human rhinoviruses) in high-risk patients."

Researchers claim that this drug can kill majority of common cold virus within a few hours. Researchers affirm that this drug will be available within five years after the completion of the human trails.